Literature DB >> 20117012

Postoperative psychiatric disorders in general thoracic surgery: incidence, risk factors and outcomes.

Mehmet Oğuzhan Ozyurtkan1, Bedrettin Yildizeli, Kemal Kuşçu, Nural Bekiroğlu, Korkut Bostanci, Hasan Fevzi Batirel, Mustafa Yüksel.   

Abstract

OBJECTIVE: Postoperative psychiatric disorders (PPDs) may complicate the post-surgical outcome. We analysed the types, incidences, risk factors and outcomes of the PPDs in non-cardiac thoracic surgery patients.
METHODS: All patients (n=100) undergoing major non-cardiac thoracic surgery from January 2004 to March 2005 were investigated prospectively. The diagnosis of PPD was made based on the Diagnosis and Statistical Manual of Mental Disorders. The patients were grouped into two according to the presence (group I) or absence (group II) of PPD. Data on pre-, per- and postoperative factors, and the adverse outcomes were analysed.
RESULTS: Eighteen patients (18%) developed PPD, including delirium in 44%, adjustment disorders in 22%, panic attack in 17%, minor depression in 11% and psychosis in 6%. The patients who developed PPD were older (58+/-17 vs 50+/-15 years, p=0.05), had a longer operation time (6+/-1 vs 5+/-2h, p=0.015) and hospital stay (13+/-9 vs 8+/-5 days, p=0.019). The morbidity and mortality rates were not significantly different between the groups (67% vs 46%; 11% vs 1%, respectively). The causative factors in the development of PPD were older age, longer operation time, abnormal serum chemistry values of sodium, potassium, calcium and glucose, hypoalbuminaemia, the presence of the postoperative respiratory distress and infection and blood transfusion (p<0.05).
CONCLUSIONS: PPDs are associated with adverse outcomes including a longer hospital stay, and increased morbidity and mortality rates. The identification, detection and elimination of these risk factors are recommended. Copyright 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117012     DOI: 10.1016/j.ejcts.2009.11.047

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

1.  Postoperative Delirium in Lung Cancer Anatomical Resection-Analysis of Risk Factors and Prognosis.

Authors:  Hironori Ishibashi; Ryo Wakejima; Ayaka Asakawa; Yusuke Sugita; Yuya Ishikawa; Mariko Hanafusa; Shunichi Baba; Yasuhiro Nakashima; Katsutoshi Seto; Kenichi Okubo
Journal:  World J Surg       Date:  2022-01-13       Impact factor: 3.352

2.  Complex assessment of the incidence and risk factors of delirium in a large cohort of cardiac surgery patients: a single-center 6-year experience.

Authors:  Lukasz J Krzych; Maciej T Wybraniec; Irena Krupka-Matuszczyk; Michał Skrzypek; Anna Bolkowska; Mirosław Wilczyński; Andrzej A Bochenek
Journal:  Biomed Res Int       Date:  2013-12-22       Impact factor: 3.411

3.  Prevalence and risk factors of postoperative delirium in elderly hip fracture patients.

Authors:  Yong Guo; Peiyu Jia; Junfeng Zhang; Xuemin Wang; Hong Jiang; Wei Jiang
Journal:  J Int Med Res       Date:  2016-02-26       Impact factor: 1.671

4.  Glucose variability during delirium in diabetic and non-diabetic intensive care unit patients: A prospective cohort study.

Authors:  Kris van Keulen; Wilma Knol; Svetlana V Belitser; Irene J Zaal; Paul D van der Linden; Eibert R Heerdink; Toine C G Egberts; Arjen J C Slooter
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

5.  Effective prediction of postoperative complications for patients after open hepatectomy: a simplified scoring system based on perioperative parameters.

Authors:  Long Chen; Yun-Bing Wang; Yan-Hong Zhang; Jun-Fei Gong; Yue Li
Journal:  BMC Surg       Date:  2019-09-05       Impact factor: 2.102

6.  Postoperative delirium after lung resection for primary lung cancer: Risk factors, risk scoring system, and prognosis.

Authors:  Kazuki Hayashi; Makoto Motoishi; Satoru Sawai; Kanna Horimoto; Jun Hanaoka
Journal:  PLoS One       Date:  2019-11-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.